These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 12183722

  • 21. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC, Grant DB.
    Acta Paediatr; 1995 Aug; 84(8):899-903. PubMed ID: 7488814
    [Abstract] [Full Text] [Related]

  • 22. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
    J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
    [Abstract] [Full Text] [Related]

  • 23. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar 01; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 24. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov 01; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 25. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
    Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
    J Pediatr Endocrinol Metab; 2006 Mar 01; 19(3):245-51. PubMed ID: 16607925
    [Abstract] [Full Text] [Related]

  • 26. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.
    Balsamo A, Cicognani A, Baldazzi L, Barbaro M, Baronio F, Gennari M, Bal M, Cassio A, Kontaxaki K, Cacciari E.
    J Clin Endocrinol Metab; 2003 Dec 01; 88(12):5680-8. PubMed ID: 14671153
    [Abstract] [Full Text] [Related]

  • 27. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR, Kelnar CJ, Wallace AM.
    J Paediatr Child Health; 1993 Aug 01; 29(4):302-4. PubMed ID: 8373678
    [Abstract] [Full Text] [Related]

  • 28. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
    Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE.
    J Clin Endocrinol Metab; 2006 Jun 01; 91(6):2179-84. PubMed ID: 16551734
    [Abstract] [Full Text] [Related]

  • 29. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY, Lee CT, Tung YC, Chien YH, Hwu WL, Tsai WY.
    J Formos Med Assoc; 2018 Feb 01; 117(2):126-131. PubMed ID: 28392195
    [Abstract] [Full Text] [Related]

  • 30. Growth in congenital adrenal hyperplasia.
    Nguyen AT, Brown JJ, Warne GL.
    Indian J Pediatr; 2006 Jan 01; 73(1):89-93. PubMed ID: 16444069
    [Abstract] [Full Text] [Related]

  • 31. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
    Sellick J, Aldridge S, Thomas M, Cheetham T.
    J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
    [Abstract] [Full Text] [Related]

  • 32. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT, Tung YC, Hsiao PH, Lee JS, Tsai WY.
    J Formos Med Assoc; 2010 Feb 25; 109(2):148-55. PubMed ID: 20206839
    [Abstract] [Full Text] [Related]

  • 33. Long-term Growth in Congenital Adrenal Hyperplasia.
    Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
    Indian J Pediatr; 2019 Feb 25; 86(2):154-158. PubMed ID: 30097840
    [Abstract] [Full Text] [Related]

  • 34. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency.
    Chakhtoura Z, Bachelot A, Samara-Boustani D, Ruiz JC, Donadille B, Dulon J, Christin-Maître S, Bouvattier C, Raux-Demay MC, Bouchard P, Carel JC, Leger J, Kuttenn F, Polak M, Touraine P, Centre des Maladies Endocriniennes Rares de la Croissance and Association Surrénales.
    Eur J Endocrinol; 2008 Jun 25; 158(6):879-87. PubMed ID: 18390993
    [Abstract] [Full Text] [Related]

  • 35. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.
    Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ, Montori VM.
    J Clin Endocrinol Metab; 2010 Sep 25; 95(9):4161-72. PubMed ID: 20823467
    [Abstract] [Full Text] [Related]

  • 36. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
    Sarafoglou K, Addo OY, Turcotte L, Otten N, Wickremasinghe A, Pittock S, Kyllo J, Lteif AN, Himes JH, Miller BS.
    J Pediatr; 2014 May 25; 164(5):1141-1146.e1. PubMed ID: 24560184
    [Abstract] [Full Text] [Related]

  • 37. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
    Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
    J Steroid Biochem Mol Biol; 2017 Jan 25; 165(Pt B):396-406. PubMed ID: 27544322
    [Abstract] [Full Text] [Related]

  • 38. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Cunha HM, Elias LL, Camacho-Hübner C, Moreira AC, Martinelli CE.
    Clin Endocrinol (Oxf); 2004 Jul 25; 61(1):94-101. PubMed ID: 15212650
    [Abstract] [Full Text] [Related]

  • 39. Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Oswiecimska JM, Ksiazek A, Sygulla K, Pys-Spychala M, Roczniak GR, Roczniak W, Stojewska M, Ziora K.
    Neuro Endocrinol Lett; 2012 Jul 25; 33(8):787-91. PubMed ID: 23391972
    [Abstract] [Full Text] [Related]

  • 40. Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency.
    Jääskeläinen J, Kiekara O, Hippeläinen M, Voutilainen R.
    J Endocrinol Invest; 2000 Jan 25; 23(1):23-7. PubMed ID: 10698047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.